NCT06488547 Stress and Musculoskeletal Health in Employees
| NCT ID | NCT06488547 |
| Status | Recruiting |
| Phase | — |
| Sponsor | University of Thessaly |
| Condition | Musculoskeletal Diseases or Conditions |
| Study Type | INTERVENTIONAL |
| Enrollment | 57 participants |
| Start Date | 2024-06-01 |
| Primary Completion | 2026-12-31 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 57 participants in total. It began in 2024-06-01 with a primary completion date of 2026-12-31.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
This study aims to evaluate potential correlation of stress as estimated by certain biological markers, namely saliva cortisol, Heart rate variability (HRV), Electromyography (EMG) with musculoskeletal system health status, and assess the impact of a stress management intervention..The intervention group will be trained to apply two evidence based stress management techniques and they will be guided with tips and advice about musculoskeletal health. Impact of the intervention upon measured stress related markers will be assessed.
Eligibility Criteria
Inclusion Criteria: * Writing and reading greek. * Consent to provide their medical history. * Consent to be measured with electronic devices. Exclusion Criteria: * Employees who are close to retirement (at least 2 years before) and those for whom any known factor may prevent them from completing the intervention (eg travel, transfer). * Pregnancy. * Pacemaker, history of seizures. * Diagnosed musculoskeletal injury. * Diagnosed diseases such as: osteoarthritis, autoimmune diseases (rheumatoid arthritis, lupus, etc.), stroke, myocardial infarction, malignant neoplasms, psychiatric disease, disability. * Systematic reception of cortisone and anti-inflammatory treatment, up to at least three months before the intervention. * Drugs or substances. * Participation in another interventional program of musculoskeletal rehabilitation, physical therapy, stress management or health promotion.
Contact & Investigator
Eleni Zigkiri, PhD (c)
PRINCIPAL INVESTIGATOR
University of Thessaly
Frequently Asked Questions
Who can join the NCT06488547 clinical trial?
This trial is open to participants of all sexes, aged 19 Years or older, studying Musculoskeletal Diseases or Conditions. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT06488547 currently recruiting?
Yes, NCT06488547 is actively recruiting participants. Contact the research team at ezigkiri@uth.gr for enrollment information.
Where is the NCT06488547 trial being conducted?
This trial is being conducted at Larissa, Greece, Athens, Greece.
Who is sponsoring the NCT06488547 clinical trial?
NCT06488547 is sponsored by University of Thessaly. The principal investigator is Eleni Zigkiri, PhD (c) at University of Thessaly. The trial plans to enroll 57 participants.